Cyteir Therapeutics, Inc. Stock
Equities
CYTT
US23284P1030
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 16-04-30 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 20-11-30 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 22-02-03 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 16-04-30 |
Jean George
BRD | Director/Board Member | 66 | 13-03-31 |
1st Jan change | Capi. | |
---|---|---|
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |